Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

ZYUS Life Sciences Announces Chief Financial Officer Transition

11/30/2021 | 05:06pm EST

ZYUS Life Sciences Inc. ("ZYUS"), a next-generation life sciences company leading scientific research and development in phyto-therapeutics, is announcing a transition of its Chief Financial Officer (“CFO”) position. Effective December 6, 2021, John Hyshka will become acting CFO, replacing current CFO Rob Harding. Mr. Hyshka is an experienced business and finance leader based in Saskatchewan with strong experience establishing and scaling high-growth companies, including in the life sciences space.

Mr. Hyshka, former CFO of Phenomenome Discoveries Inc. (“PDI”) for nearly 15 years brings more than two decades of financial experience in the life sciences industry. Throughout his career, Mr. Hyshka has been successful in leading multi-million-dollar financings for smaller enterprises in the agriculture, medical device, and therapeutics industries.

“We are pleased to welcome John Hyshka as acting CFO,” said Brent Zettl, ZYUS CEO. “Mr. Hyshka’s extensive experience in the life sciences industry and proven track record as a finance leader and in raising capital will be a valuable addition to our leadership team.”

Rob Harding, ZYUS’ current CFO, recently announced his resignation to pursue other opportunities. Mr. Harding leaves the company with the respect and appreciation of the ZYUS team, who extend their thanks and best wishes to Mr. Harding in his future endeavours.

About ZYUS Life Sciences Inc.

ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. Through clinical research and IP development, we intend to deliver high-quality oils, softgels, topical creams and other cannabinoid-based therapeutics and product candidates to patients worldwide. The ZYUS vision is to elevate cannabinoids as a standard of care and expand the potential of protein-based formulations in pursuit of a transformational impact on patients’ lives. ZYUS: Advancing the Science of Well-Being. Visit www.zyus.com

Forward-Looking Information

This news release contains forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of ZYUS to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These forward-looking statements include, but are not limited to expectations with respect to our business plans, future financial condition, research activities and product lines.

Often, but not always, forward-looking statements can be identified by the use of words such as “expects,” “expected,” “expectation,” “anticipates,” “believes,” “intends,” “estimates,” “predicts,” “continues,” “potential,” “targeted,” “plans,” “possible” and similar expressions, or statements that events, conditions or results “will,” “may,” “could,” “would” or “should” occur or be achieved, or the negative of these terms or other comparable terminology. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements.

Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements contained in this news release are made as of the date of this release and, accordingly, are subject to change after such date. ZYUS does not assume any obligation to update or revise any forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf, except as required by applicable law.


ę Business Wire 2021
Latest news "Companies"
12:31pMIGO Opportunities Trust Plc - Issue of Equity
PR
12:31pDEADLINE ALERT FOR Z, ZG, LSPD, AND OWLT : The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GL
12:30pInflation in Nigeria Rose to 15.63% in December
DJ
12:30pPharmAla Biotech initiates research at the University of Arkansas for Medical Sciences
AQ
12:30pICG ENTERPRISE TRUST PLC : Notification of Transactions of Persons Discharging Managerial Responsibilities
AQ
12:30pASHTEAD GROUP PLC - Transaction in Own Shares
PR
12:29pAtlantia to buy $1 bln Yunex Traffic from Siemens
RE
12:27pPIMCO Canada Corp.áAnnounces Monthly Distributions for PIMCO Canada Exchange Traded Series
GL
12:25pHORMEL FOODS : PLANTERS Is Hiring a Crew of ‘Peanutters' to Drive a 26-Foot Nut Called the Nutmobile
PU
12:25pHORMEL FOODS : The Best Peanut Butter Cups You Can Buy, According to Candy Fanatics
PU
Latest news "Companies"